BackSyncom Formulations (India) Limited Overview

Syncom Formulations (India) Limited Total Liabilities

Track Syncom Formulations (India) Limited's total liabilities ($-4.1B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$-4.15B
↑ 21.29% YoYΔ $-728.31M vs prior year quarter

Peer trimmed avg / median

Loading

Syncom Formulations (India) Limited Total Liabilities History

Loading

Syncom Formulations (India) Limited vs. peers: Total Liabilities Comparison

Loading

Syncom Formulations (India) Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Syncom Formulations (India) Limited (SYNCOMF.NS) FAQ

The latest total liabilities for SYNCOMF.NS is $-4.1B as of June 2026. That compares with $-3.4B in the prior-year period — down 21.3% year over year. Investors often review this figure alongside Syncom Formulations (India) Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, SYNCOMF.NS's total liabilities moved from $-3.4B to $-4.1B — a 21.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Syncom Formulations (India) Limited's operating scale or balance-sheet position.

A total liabilities figure of $-4.1B for SYNCOMF.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SYNCOMF.NS's total liabilities ($-4.1B), review year-over-year change from $-3.4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.